ENTITY

MorphoSys AG (MOR US)

6
Analysis
Health Care • Germany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
more
bullish•Eoflow
•26 May 2024 07:00

Last Week in Event SPACE: Mitsui Matsushima, L'Occitane, Prosus/Tencent, EOFlow

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
730 Views
Share
bullish•Hypoport
•21 May 2024 18:22

Quiddity Leaderboard DAX/MDAX Jun 24: Hellofresh MDAX Deletion Hinges on Encavis Tender Offer Result

Hellofresh could be deleted from the MDAX index in June 2024. However, this depends on the final outcome of the Encavis Tender Offer.

Share
•28 Apr 2024 07:00

Last Week in Event SPACE: HK Southbound, Jardine Cycle, Keisei/Oriental Land, BHP/Anglo American

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
602 Views
Share
bullish•Darktrace
•25 Apr 2024 18:28

Quiddity Leaderboard SE600 Mar 24: 7 Changes Likely; Expected ADDs Could Outperform Expected DELs

My latest estimate for one-way flow is US$95mn. The expected ADDs have strong positive momentum while the expected DELs have strong negative momentum.

Share
bullish•Traton SE
•24 Apr 2024 15:13

Quiddity Leaderboard DAX/MDAX Mar 24: Traton Could Outperform the DAX Index

Commercial vehicle manufacturer Traton is a strong candidate for MDAX addition. The expected index flow could act as a catalyst and help the stock...

Share
x